-+ 0.00%
-+ 0.00%
-+ 0.00%

Monte Rosa to Launch Phase 2 Trial of MRT-2359 Plus AR Inhibitor in AR-Mutant mCRPC in Q3 2026

Reuters·02/24/2026 12:04:04

Please log in to view news